deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01094223

Mindfulness Based Relapse Prevention for Stimulant Users (MBRP)

Sponsor: University of California, Los Angeles

Updated 7 times since 2017 Last updated: Apr 22, 2022 Started: Apr 30, 2010 Primary completion: Apr 30, 2012 Completion: Dec 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Stimulant Dependence and is currently completed. University of California, Los Angeles leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotActive Not Recruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~May 2022 · 16 months · monthly snapshotUnknown Status~May 2022 – ~Jul 2024 · 26 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. May 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  4. Jan 2021 — May 2022 [monthly]

    Unknown Status NA

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

Show 2 earlier versions
  1. Feb 2018 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  2. Jan 2017 — Feb 2018 [monthly]

    Active Not Recruiting NA

    First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations